We have reported here the results of studies of the immunogenicity and reactogenicity of this vaccine in patients at increased risk of severe influenza or developing influenza-related ...
Background: The trivalent inactivated split-influenza vaccine, Fluarix TM has been available since 1992. Aim: To assess the safety and immunogenicity of the vaccine from studies in healthy adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback